Salmeterol Xinafoate
Salmeterol xinafoate is a selective, long-acting beta2-adrenergic receptor agonist (LABA). It acts locally in the lung as a bronchodilator to relax bronchial smooth muscles and improve airflow, with a duration of action lasting approximately 12 hours. It is used for long-term control and is not a rescue medication; it should not be used to treat acute asthma attacks.
Dosage by Body Weight
The standard dose for adults and children 4 years of age and older is 50 mcg (1 inhalation) twice daily, approximately 12 hours apart. For asthma management, it must always be used in combination with an inhaled corticosteroid (ICS). It is not recommended for children under 4 years of age.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established in infants.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and efficacy have not been established.
- Body Weight
- 11-15 kg
- Dose
- 50 mcg (1 inhalation)
- Frequency
- Twice daily
- Tracking Notes
- Only for children aged 4 years and older as prescribed by a specialist. Must be used with an inhaled corticosteroid.
- Body Weight
- 16-20 kg
- Dose
- 50 mcg (1 inhalation)
- Frequency
- Twice daily
- Tracking Notes
- Only for children aged 4 years and older. Must be used with an inhaled corticosteroid.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and efficacy have not been established in infants. |
| 5-7 kg | Not recommended | Do not use | Safety and efficacy have not been established. |
| 8-10 kg | Not recommended | Do not use | Safety and efficacy have not been established. |
| 11-15 kg | 50 mcg (1 inhalation) | Twice daily | Only for children aged 4 years and older as prescribed by a specialist. Must be used with an inhaled corticosteroid. |
| 16-20 kg | 50 mcg (1 inhalation) | Twice daily | Only for children aged 4 years and older. Must be used with an inhaled corticosteroid. |
Formulation
Purpose
Long-term maintenance treatment of asthma and prevention of bronchospasm in patients with reversible obstructive airway disease, and maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).
Generic Name
Salmeterol xinafoateBranded Drug Names
Salmeterol Xinafoate is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.